Innophos Holdings, Inc. (IPHS) Shares Bought by Confluence Investment Management LLC
Confluence Investment Management LLC increased its position in Innophos Holdings, Inc. (NASDAQ:IPHS) by 3.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 96,576 shares of the specialty chemicals company’s stock after buying an additional 3,082 shares during the period. Confluence Investment Management LLC’s holdings in Innophos were worth $4,513,000 at the end of the most recent quarter.
Several other large investors have also recently bought and sold shares of IPHS. Old Mutual Global Investors UK Ltd. bought a new stake in Innophos during the third quarter worth approximately $109,000. Public Employees Retirement System of Ohio increased its stake in Innophos by 5.9% during the second quarter. Public Employees Retirement System of Ohio now owns 2,824 shares of the specialty chemicals company’s stock worth $124,000 after acquiring an additional 157 shares during the last quarter. Macquarie Group Ltd. bought a new stake in Innophos during the third quarter worth approximately $193,000. Piedmont Investment Advisors LLC bought a new stake in Innophos during the third quarter worth approximately $209,000. Finally, Pacad Investment Ltd. increased its stake in Innophos by 19.5% during the second quarter. Pacad Investment Ltd. now owns 4,900 shares of the specialty chemicals company’s stock worth $215,000 after acquiring an additional 800 shares during the last quarter. Institutional investors own 94.46% of the company’s stock.
Several brokerages have weighed in on IPHS. BidaskClub cut Innophos from a “hold” rating to a “sell” rating in a research note on Tuesday, December 5th. Zacks Investment Research cut Innophos from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 4th. Finally, KeyCorp reissued a “hold” rating on shares of Innophos in a research note on Wednesday, November 1st.
Innophos (NASDAQ:IPHS) last issued its quarterly earnings data on Tuesday, October 31st. The specialty chemicals company reported $0.78 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.72 by $0.06. Innophos had a return on equity of 13.90% and a net margin of 6.19%. The company had revenue of $184.00 million for the quarter, compared to analysts’ expectations of $179.33 million. During the same period in the previous year, the firm posted $0.69 earnings per share. The firm’s revenue for the quarter was down 1.1% on a year-over-year basis. equities analysts predict that Innophos Holdings, Inc. will post 2.5 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Innophos Holdings, Inc. (IPHS) Shares Bought by Confluence Investment Management LLC” was originally reported by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/innophos-holdings-inc-iphs-shares-bought-by-confluence-investment-management-llc/1800716.html.
Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.
Want to see what other hedge funds are holding IPHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innophos Holdings, Inc. (NASDAQ:IPHS).
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.